Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Pharmaceutical service provider integrates sustainability goals into its corporate strategy
Released By Vetter Pharma International
January 16, 2023
Ravensburg, June 1, 2022 – Vetter, a global leading Contract Development and Manufacturing Organization (CDMO), has published its first sustainability report. The report underpins the company’s commitment to sustainable action and covers three areas: Ecological Responsibility, Sustainable Economy, and Social Engagement. In doing so, the CDMO is orienting its activities to the UN Sustainable Development Goals. “As a family-owned business, we think in the long term and aim to act in an economically, socially, and ecologically responsible manner,” says Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family. And Vetter lives up to this responsibility. For many years the pharmaceutical service provider has been realizing a comprehensive sustainability program through its comprehensive EHS (Environment, Health, and Safety) management. Now the company is going one step further. “With the publication of our first sustainability report, we are committing ourselves to the future and making our previous measures on the subject of sustainability transparent for everyone to understand,” emphasizes Senator h.c. Udo J. Vetter. And these measures are multifaceted, encompassing the areas of ecology, economy, and social issues in their interplay. “Sustainability is firmly anchored in our corporate philosophy,” says Vetter Managing Director Peter Soelkner. “Of course, on many levels, it also plays an important role in our current corporate strategy Vetter NExT 2029.” All stakeholders are included in the process. Thus, the report also shows the individual importance of sustainable action for patients and their families, customers, employees, partner companies as well as society overall. The company‘s sustainability goals are aligned with the requirements for the Sustainable Development Goals (SDGs) of the United Nations. Ecological responsibility – looking to future generations “We are very aware of our social responsibility towards future generations,” emphasizes Vetter Managing Director Thomas Otto. “One of our main initiatives is therefore, to further reduce our emissions, energy consumption, and waste volumes, while at the same time meeting the high regulatory requirements within the manufacturing of vital medicines.” Since 2021, all Vetter sites worldwide have been CO2-neutral. In addition, the company attaches great importance to the stable supply of green electricity from hydroelectric power plants as well as the use of energy from cogeneration units, photovoltaic systems, and geothermal energy. By realizing efficiency measures, the CDMO has saved more than 31 million KWh of energy over the past ten years and expects to further reduce energy consumption an additional 10% by 2029. Through the use of green technology and targeted investments that are in line with the German government’s technology strategy, the company was already using 1,562 m3 less water in 2021, for example, or the equivalent annual consumption of 34 people. Sustainable economy – value creation and occupational safety Vetter’s entrepreneurial goal is to create sustainable value. Implementing a sustainability strategy is an integral part of its business model. Another focus is on the promotion as well as the protection of its employees. With a comprehensive occupational health and safety management system, the pharmaceutical service provider creates a safe working environment. In addition, Vetter invests in high-quality education of its employees through continuous training. Social commitment – Social sustainability As a globally acting company, Vetter currently employs 5,700 people from over 60 different nations and has been a member of the Diversity Charter since 2017. The CDMO is committed to a prejudice-free, appreciative working environment in which equal opportunities prevail for all employees – regardless of characteristics such as gender identity, ethnic origin, nationality, and age. “At the same time, we are aware that social responsibility extends well beyond our own company,” says Managing Director Peter Soelkner. “That is why we are actively involved in various initiatives around our corporate sites.” About the Vetter Sustainability Report The structure of the report is based on the requirements of the German Sustainability Code (DNK). In addition, the content was reviewed against the internationally recognized Sustainability Report Standards (SRS), the Global Reporting Initiative (GRI), and the principles of completeness, materiality, and stakeholder engagement. “Our first sustainability report is another important milestone in Vetter’s corporate history. Even though we look with pride at the results achieved thus far, we see it, above all, as an incentive and motivation to continuously realize our further goals,” Managing Director Thomas Otto sums up. The complete sustainability report can be found here.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !